Drug coverage, utilization, and spending by Medicare beneficiaries with heart disease
Related Experiment Video
Updated: Sep 11, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Ravi Sharma1, Hongji Liu, Yinghua Wang
1Westat, RP5022, MCBS Survey Operations, 1650 Research Boulevard, Rockville, MD 20850, USA. ravisharma@westat.com
Abstract:
For Medicare beneficiaries who report having heart disease, drug coverage and type of supplemental health insurance affect the likelihood of usage and costs of heart medications, but not the extent of usage. Nearly one in five does not use heart medications and of the latter, one-third lack drug coverage. Some non-users without drug coverage go without prescribed heart medications because of limited financial access. Compared to non-users with coverage, they utilize medical provider services more, and if hospitalized, their inpatient costs are twice as high. Medicare may accrue cost savings by providing drug coverage to and monitoring these at-risk beneficiaries.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease V: Interprofessional Care
Heart Failure V: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy

